Cyclin D1 gene polymorphism is associated with increased risk of urinary bladder cancer

Akita University, Akita, Akita, Japan
Carcinogenesis (Impact Factor: 5.33). 03/2002; 23(2):257-64. DOI: 10.1093/carcin/23.2.257
Source: PubMed


Cyclin D1 is believed to play an important role in the genesis and/or progression of transitional cell cancer (TCC) of the urinary bladder. Cyclin D1 gene (CCND1) mRNA is alternatively spliced to produce two transcripts, and the splicing pattern may be modulated by a G to A single nucleotide polymorphism within the splice donor site of exon 4. This study was conducted to explore the association between the polymorphism and the susceptibility to and disease status of TCC of the bladder in 222 cases and 317 native Japanese controls. The relationship between the CCND1 polymorphism and the mRNA splicing pattern in TCC cells was evaluated by semi-quantitative reverse-transcription PCR. The CCND1 A allele was more frequently observed in the TCC group than the control group (P = 0.032) with a significant difference in the genotype frequency between the two groups (P = 0.029). The AA genotype was associated with a significantly higher risk of TCC compared with the AG+GG genotypes (adjusted odds ratio (aOR) = 1.76, 95% confidence interval (CI) = 1.09-2.84, P = 0.022). This association was observed more significantly in nonsmoking cases (aOR = 2.53; 95% CI = 1.28-4.51, P = 0.008). Looking at tumor grade, the presence of the A allele was associated with higher grade (= grade 3) tumors with a gene dosage effect (aOR = 1.77, CI = 1.16-2.69, P = 0.008). In tumor stage, although not significant, the AA + AG genotypes tended to be more frequently observed in cases with T1-4 tumors than those with Ta tumors (aOR = 1.94, 95% CI = 0.98-3.82, P = 0.057). The genotype seemed to influence the two alternatively spliced forms of the CCND1 mRNA because the ratio of the CCND1 transcript-b/transcript-a was significantly higher in cases with the AA genotype compared with those with the AG + GG genotypes. These data suggest that the CCND1 variant A allele may be associated with an increased risk of TCC of the bladder, especially in men without a history of smoking, and it may also have an effect on its disease status.

Full-text preview

Available from:
  • Source
    • "The presence of the AhR rs2066853 (Arg554Lys) polymorphism was determined by using the TaqMan probe C_11170747_20 from Applied Biosystems, according to the manufacturer's recommendations . Restriction fragment length polymorphism (RFLP) analysis was used to assess the following polymorphisms: CYP1A1 rs4646903 (6235T > C) and CYP1A1 rs1800031 (5639T > C) (Kawajiri, 1999), CYP1A1 rs1048943 (Ile462Val) and CYP1A1 rs1799814 (Thr461Asn) (Cascorbi et al., 1996), CYP2E1 rs2031920 (-1053C > T) (Morita et al., 1997), EPHX1 rs1051740 (Tyr113His) and EPHX1 rs2234922 (His139Arg) (Smith and Harrison, 1997), GSTPI rs947894 (Ile105Val) (Harries et al., 1997), XRCC1 rs25487 (Arg399Gln) (Abdel-Rahman and El-Zein, 2000), ERCC2 rs13181 (Lys751Gln) (Lunn et al., 2000), MGMT rs12917 (Leu84Phe) (Courtney et al., 2005), CCND1 rs603965 (870G > A) (Wang et al., 2002), and TP53 rs1042522 (Arg72Pro) (Irarrázabal et al., 2003). Polymorphisms of GSTT1 null and GSTM1 null were determined by multiplex PCR using a previously reported protocol (Abdel-Rahman et al., 1996). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lung cancer is the leading cause of cancer mortality in Mexico and worldwide. In the past decade, there has been an increase in the number of lung cancer cases in young people, which suggests an important role for genetic background in the etiology of this disease. In this study, we genetically characterized 16 polymorphisms in 12 low penetrance genes (AhR, CYP1A1, CYP2E1, EPHX1, GSTM1, GSTT1, GSTPI, XRCC1, ERCC2, MGMT, CCND1 and TP53) in 382 healthy Mexican Mestizos as the first step in elucidating the genetic structure of this population and identifying high risk individuals. All of the genotypes analyzed were in Hardy-Weinberg equilibrium, but different degrees of linkage were observed for polymorphisms in the CYP1A1 and EPHX1 genes. The genetic variability of this population was distributed in six clusters that were defined based on their genetic characteristics. The use of a polygenic model to assess the additive effect of low penetrance risk alleles identified combinations of risk genotypes that could be useful in predicting a predisposition to lung cancer. Estimation of the level of genetic susceptibility showed that the individual calculated risk value (iCRV) ranged from 1 to 16, with a higher iCRV indicating a greater genetic susceptibility to lung cancer.
    Full-text · Article · Oct 2011 · Genetics and Molecular Biology
  • Source
    • "We further demonstrated that through the activation of ERK1/2 and Stat3 signal pathways, nicotine exposure perturbs cell cycle progression, leading to increased S phase, expression of Cyclin D1, Cyclin A, PCNA, and Rb phosphorylation. The amplification of Cyclin D1 genes have been reported in many types of cancers, including bladder cancer (Wang et al., 2002). The detailed molecular signaling mechanisms bridging nicotine stimulation and Cyclin D1 expression have never been studied in bladder epithelial cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cigarette smoke is a major risk factor for bladder cancer. The main component in cigarette smoke, nicotine, can be detected in the urine of smokers. Nicotine has been implicated as a cocarcinogen that promotes lung cancer development through prosurvival pathways. Although the mechanisms of nicotine-induced cell proliferation have been well studied in lung epithelial cells, the molecular mechanism of its action in bladder epithelial cells is still unclear. The aims of this study were to investigate whether there is nicotine-induced bladder epithelial cell proliferation and to identify the signaling transduction pathway regulated by nicotine. We found that nicotine simultaneously activates Stat3 and extracellular signal regulated kinase 1/2 (ERK1/2) in T24 cells. Stat3 activation via nicotinic acetylcholine receptor (nAChR)/protein kinase C signaling pathway was closely linked to Stat3 induction and nuclear factor-kappaB DNA binding activity, which is associated with Cyclin D1 expression and cell proliferation. ERK1/2 activation through nAChR and beta-adrenoceptors plays a dual role in cell proliferation; it phosphorylates Stat3 at Ser727 and regulates cell proliferation. We conclude that through nAChR and beta-adrenoceptors, nicotine activates ERK1/2 and Stat3 signaling pathways, leading to Cyclin D1 expression and cell proliferation. This is the first study to investigate signaling effects of nicotine in bladder cells. The current findings suggest that people exposed to nicotine could be at risk for potential deleterious effects, including bladder cancer development.
    Full-text · Article · Sep 2008 · Toxicological Sciences
  • Source
    • "A number of studies have looked at variants in genes in the various DNA repair pathways, mainly focusing on the BER and NER pathways, and also cell cycle genes [6,17-20,23-25] and association with bladder cancer. No single variant has been conclusively associated with bladder cancer risk. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chemicals from occupational exposure and components of cigarette smoke can cause DNA damage in bladder urothelium. Failure to repair DNA damage by DNA repair proteins may result in mutations leading to genetic instability and the development of bladder cancer. Immunohistochemistry studies have shown DNA damage signal activation in precancerous bladder lesions which is lost on progression, suggesting that the damage signalling mechanism acts as a brake to further tumorigenesis. Single nucleotide polymorphisms (SNPs) in DSB signalling genes may alter protein function. We hypothesized that SNPs in DSB signalling genes may modulate predisposition to bladder cancer and influence the effects of environmental exposures. We recruited 771 cases and 800 controls (573 hospital-based and 227 population-based from a previous case-control study) and interviewed them regarding their smoking habits and occupational history. DNA was extracted from a peripheral blood sample and genotyping of 24 SNPs in MRE11, NBS1, RAD50, H2AX and ATM was undertaken using an allelic discrimination method (Taqman). Smoking and occupational dye exposure were strongly associated with bladder cancer risk. Using logistic regression adjusting for age, sex, smoking and occupational dye exposure, there was a marginal increase in risk of bladder cancer for an MRE11 3'UTR SNP (rs2155209, adjusted odds ratio 1.54 95% CI (1.13-2.08, p = 0.01) for individuals homozygous for the rare allele compared to those carrying the common homozygous or heterozygous genotype). However, in the hospital-based controls, the genotype distribution for this SNP deviated from Hardy-Weinberg equilibrium. None of the other SNPs showed an association with bladder cancer and we did not find any significant interaction between any of these polymorphisms and exposure to smoking or dye exposure. Apart from a possible effect for one MRE11 3'UTR SNP, our study does not support the hypothesis that SNPs in DSB signaling genes modulate predisposition to bladder cancer.
    Full-text · Article · Jul 2008 · BMC Medical Genetics
Show more